Skúšobnú verziu novej webovej stránky nájdete na beta.sukl.sk. Všetky aktuality, informácie a kompletný obsah sú zatiaľ prioritne dostupné na pôvodnej verzii webu.
en

PRODUCT DETAIL

Linagliptin Sandoz 5 mg

Code 1872F
MA number 18/0386/25-S
Product Form: tbl flm 120x5 mg (fľ.HDPE)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
MAH, country: Sandoz Pharmaceuticals d.d., Slovenia
Therapeutic Class: 18 - ANTIDIABETICA (VRÁTANE INZULÍNU)
ATC:
A ALIMENTARY TRACT AND METABOLISM
A10 DRUGS USED IN DIABETES
A10B Blood glucose lowering drugs, excl. insulins
A10BH Dipeptidyl peptidase 4 (DPP-4) inhibitors
A10BH05 Linagliptin
Shelf life: 36
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 06.12.2025
Validity: 06.12.2030
PIL: PIL_Linagliptin Sandoz 5 mg_11 2025.pdf  
SPC: SPC_Linagliptin Sandoz 5 mg_11 2025.pdf  
Safety feature Yes
Data update: 11.12.2025
eu-flag.png sk-flag.png